Iridex Corp stock is traded at $0.445, with a volume of 48,739. It is down -4.58% in the last 24 hours and down -41.07% over the past month. IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Previous Close:
$0.4663
Open:
$0.478
24h Volume:
48,739
Relative Volume:
0.47
Market Cap:
$7.92M
Revenue:
$52.58M
Net Income/Loss:
-$3.28M
P/E Ratio:
-
EPS:
-$0.1927
Net Cash Flow:
-$2.53M
1W Performance:
-35.51%
1M Performance:
-41.07%
6M Performance:
-55.51%
1Y Performance:
-52.66%
1-Day Range:
$0.4296$0.478
1-Week Range:
$0.4296$0.7349
52-Week Range:
$0.4296$1.65
Iridex Corp Stock (IRIX) Company Profile
Name
Iridex CorpSector
HealthcareIndustry
Medical DevicesPhone
(650) 940-4700Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS